Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Datta Meghe Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with type 2 diabetes mellitus based on ADA criteria, residing in rural areas for at least the past 5 years, and providing informed written consent
Exclusion criteria
Exclusion criteria: Type 1 diabetes mellitus, gestational diabetes, known hemoglobinopathies or anemia, acute infection or recent hospitalization-within the last 4 weeks, incomplete clinical records, refusal of informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between HbA1c levels and presence of microvascular complications including retinopathy, nephropathy, and neuropathy and macrovascular complications including coronary artery disease, peripheral arterial disease, and cerebrovascular diseaseTimepoint: At the time of enrollment- at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of microvascular complications including retinopathy, nephropathy, & neuropathy in the study populationTimepoint: At the time of enrollment- at baseline;Prevalence of macrovascular complications including coronary artery disease, peripheral arterial disease, & cerebrovascular disease in the study populationTimepoint: At the time of enrollment- at baseline;HbA1c thresholds associated with increased risk for individual diabetic complicationsTimepoint: At the time of enrollment-at baseline;Association of duration of diabetes, age, gender, & comorbidities including hypertension & dyslipidemia with development of vascular complicationsTimepoint: At the time of enrollment-at baseline;Impact of glycemic control as measured by HbA1c on severity of diabetic complicationsTimepoint: At the time of enrollment-at baseline | — |
Countries
India
Contacts
Public ContactDr D T KATYARMAL
Datta Meghe Medical College, Wanadongri
Outcome results
None listed